AN

Axel Nils Ingvar Schorling

Active Director Director DIN 11633368
DIN 11633368 First appointment Mar 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Axel Nils Ingvar Schorling

Data last updated:

Axel Nils Ingvar Schorling is a Director at Samma Pharma India Private Limited (since 2026).

DIN 11633368
Primary Designation Director
First Appointment 27 Mar 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Samma Pharma India Private Limited U70200KA2026FTC218396
Director27 Mar 20262026Active

Board colleagues of Axel Nils Ingvar Schorling

Directorship timeline

Open interactive timeline →
Samma Pharma India Private Limited
Premium access

Shareholding and investment profile for Axel Nils Ingvar Schorling

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Axel Nils Ingvar Schorling

Axel Nils Ingvar Schorling currently holds 1 directorship: Samma Pharma India Private Limited (Director, since 27 Mar 2026).

Axel Nils Ingvar Schorling was first appointed on 27 Mar 2026 as Director at Samma Pharma India Private Limited.

The current boards of Axel Nils Ingvar Schorling's companies include Karl Nils Martin Kristofferson (Samma Pharma India Private Limited), Saravanan (Samma Pharma India Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available